In pursuit of novel ways to kill NB cells, the pro-apoptotic TNFα family cytokine Apo2L/TRAIL has been identified as a promising chemotherapeutic candidate that acts selectively on tumour but not non-transformed cells [13–18]. The gene discussed is TNFSF10; the disease is neoplasm.